Innovation Wave Thu, 30 Oct 2025 16:52:33 -0400 https://podcasters.spotify.com/pod/show/bob-mcgriff en-us © 2025 Innovation Wave yes 9352b727-82cd-5806-9376-b90b128ee1ae Bob McGriff and David Crean episodic false Buzzsprout (https://www.buzzsprout.com) Bob McGriff and David Crean https://storage.buzzsprout.com/hri4n58d9in78w3bg7hoiniyd48l?.jpg Innovation Wave https://podcasters.spotify.com/pod/show/bob-mcgriff Dr. Courtney Young, co- founder and CEO of MyoGene Bio. Dr. Courtney Young, co- founder and CEO of MyoGene Bio. Dr. Courtney Young is a prominent figure in the field of biotechnology, known for her pioneering work in gene editing therapies for rare muscle diseases. She is the co-founder and CEO of MyoGene Bio, a biotech startup focused on developing CRISPR-based therapies, particularly for Duchenne Muscular Dystrophy (DMD), a severegenetic disorder with no current cure.

]]> Dr. Courtney Young is a prominent figure in the field of biotechnology, known for her pioneering work in gene editing therapies for rare muscle diseases. She is the co-founder and CEO of MyoGene Bio, a biotech startup focused on developing CRISPR-based therapies, particularly for Duchenne Muscular Dystrophy (DMD), a severegenetic disorder with no current cure.

]]> Bob McGriff and David Crean cedab532-f1f9-4e97-9b4b-33cb8b461f82 Mon, 23 Dec 2024 11:42:48 -0500 1055 false Dr. Ana Maria Moreno is the Founder and CEO of Navega Therapeutics, Inc. Dr. Ana Maria Moreno is the Founder and CEO of Navega Therapeutics, Inc. Dr. Ana Maria Moreno is the Founder and CEO of Navega Therapeutics, Inc., a biotechnology company developing innovative gene therapies for chronic pain and other conditions.

]]> Dr. Ana Maria Moreno is the Founder and CEO of Navega Therapeutics, Inc., a biotechnology company developing innovative gene therapies for chronic pain and other conditions.

]]> Bob McGriff and David Crean d8f5197f-a410-4ba6-8dc5-7eef4b439b94 Thu, 21 Nov 2024 15:31:40 -0500 983 false Dr. Lu Yin CEO of Persperion Diagnostics Dr. Lu Yin CEO of Persperion Diagnostics Exploring the Future of Personal Diagnostics with Dr. Lu Yin of Persperion Diagnostics

]]> Exploring the Future of Personal Diagnostics with Dr. Lu Yin of Persperion Diagnostics

]]> Bob McGriff and David Crean 55a84f39-9fc0-428a-8229-27d678108121 Wed, 23 Oct 2024 23:56:17 -0400 1164 false Survive to 25' - The Life Science Ecosystem Survive to 25' - The Life Science Ecosystem Bob McGriff and David Crean discuss the current conditions in Life Science industry financing and what to look for in the second half of 2024.

]]> Bob McGriff and David Crean discuss the current conditions in Life Science industry financing and what to look for in the second half of 2024.

]]> Bob McGriff and David Crean 8a37e3d7-7cef-43df-a864-0c397ea9de2c Thu, 22 Aug 2024 11:24:13 -0400 1036 false Life Science trends and analysis 1st half 2024 Life Science trends and analysis 1st half 2024 On this episode of the podcast Bob and David discuss the current state of the life science ecosystem through the halfway point of 2024, and they offer thoughts and analysis of what to expect for the remainder of this year.

]]> On this episode of the podcast Bob and David discuss the current state of the life science ecosystem through the halfway point of 2024, and they offer thoughts and analysis of what to expect for the remainder of this year.

]]> Bob McGriff and David Crean 1e67ead3-d141-4d78-b73f-97ec7c61022a Mon, 12 Aug 2024 18:06:27 -0400 1151 false Tyrone Lam - Chief Operating Officer at GATC Health Tyrone Lam - Chief Operating Officer at GATC Health On the podcast we discuss the latest in AI-driven drug development and disease prediction.

]]> On the podcast we discuss the latest in AI-driven drug development and disease prediction.

]]> Bob McGriff and David Crean 367783fa-3ca8-4c75-810c-449a2a6488a0 Mon, 29 Apr 2024 00:10:12 -0400 1265 false Melanie Platt - Founder @ Pitch Hackerz | Mentor @ Techstars Oakland & NYC | Helped Founders Raise $500M+ Melanie Platt - Founder @ Pitch Hackerz | Mentor @ Techstars Oakland & NYC | Helped Founders Raise $500M+ Founder @ Pitch Hackerz | Mentor @ Techstars Oakland & NYC | Helped Founders Raise $500M+

]]> Founder @ Pitch Hackerz | Mentor @ Techstars Oakland & NYC | Helped Founders Raise $500M+

]]> Bob McGriff and David Crean 9a7f1f48-79d9-4ee9-a93a-08936283ba28 Fri, 12 Apr 2024 10:47:16 -0400 1241 false Tari Suprapto - Director, Search & Evaluation (West) at Novo Nordisk Tari Suprapto - Director, Search & Evaluation (West) at Novo Nordisk Dr. Tari Suprapto is recognized for her work in licensing, building, and managing strategic alliances, along with a robust technical background, highlighting her as a leader in bridging the gap between academic research and commercial applications. Tari took us through her journey and thoughts on paths to biotech innovation and the role of collaboration in today's market.

]]> Dr. Tari Suprapto is recognized for her work in licensing, building, and managing strategic alliances, along with a robust technical background, highlighting her as a leader in bridging the gap between academic research and commercial applications. Tari took us through her journey and thoughts on paths to biotech innovation and the role of collaboration in today's market.

]]> Bob McGriff and David Crean 7b006733-4c55-4f27-958c-0eca246645e8 Fri, 22 Mar 2024 11:51:41 -0400 1201 false Dr. Stanley Lewis, the Founder and CEO of A28 Therapeutics Dr. Stanley Lewis, the Founder and CEO of A28 Therapeutics Bob McGriff and David Crean 7d708736-4507-4bdb-94e1-5a88dbd54a69 Tue, 12 Mar 2024 01:49:57 -0400 1238 false Ardy Arianpour, CEO and Co-Founder of Seqster Ardy Arianpour, CEO and Co-Founder of Seqster Ardy Arianpour, CEO and Co-Founder of Seqster, joined Bob and David as guest for the Episode.  Ardy shared the founding story and his vision for how Seqster is tackling the fragmentation of healthcare data by connecting patients' disparate health information into a single, comprehensive, and actionable patient health record. Listeners will also hear Ardy’s advice to entrepreneurs looking to innovate in the healthcare technology space and what has been the most rewarding aspects of leading the company.

]]> Ardy Arianpour, CEO and Co-Founder of Seqster, joined Bob and David as guest for the Episode.  Ardy shared the founding story and his vision for how Seqster is tackling the fragmentation of healthcare data by connecting patients' disparate health information into a single, comprehensive, and actionable patient health record. Listeners will also hear Ardy’s advice to entrepreneurs looking to innovate in the healthcare technology space and what has been the most rewarding aspects of leading the company.

]]> Bob McGriff and David Crean 33c37af1-8858-487a-b693-1447b2257874 Mon, 19 Feb 2024 19:37:40 -0500 1303 false JP Morgan Healthcare Conference Recap JP Morgan Healthcare Conference Recap Cohost, David Crean, provides his insights from the recent JP Morgan healthcare conference in San Francisco in early January. David provides his insightful thoughts as it relates to mergers and acquisitions, partnering, capital financing, IPOs, and the overall outlook for 2024.

]]> Cohost, David Crean, provides his insights from the recent JP Morgan healthcare conference in San Francisco in early January. David provides his insightful thoughts as it relates to mergers and acquisitions, partnering, capital financing, IPOs, and the overall outlook for 2024.

]]> Bob McGriff and David Crean e207769b-caa3-4f0a-a1ee-dd6ea0590b85 Sun, 04 Feb 2024 23:05:48 -0500 1206 false Dr. Nazneen Dewji - Episode 10 Dr. Nazneen Dewji - Episode 10 Dr. Nazneen Dewji is a distinguished figure in the field of Alzheimer's research. She is the Founder and CEO of Cenna Biosciences, a biopharmaceutical company in La Jolla, California, dedicated to developing new treatments for Alzheimer's disease. Cenna is advancing a patented technology that targets the accumulation of the toxic Aß species, a fundamental cause of Alzheimer's, with the goal of establishing a disease-modifying drug.

]]> Dr. Nazneen Dewji is a distinguished figure in the field of Alzheimer's research. She is the Founder and CEO of Cenna Biosciences, a biopharmaceutical company in La Jolla, California, dedicated to developing new treatments for Alzheimer's disease. Cenna is advancing a patented technology that targets the accumulation of the toxic Aß species, a fundamental cause of Alzheimer's, with the goal of establishing a disease-modifying drug.

]]> Bob McGriff and David Crean a40d2338-d021-453b-96ae-6c9117f28a2e Mon, 18 Dec 2023 11:39:40 -0500 1252 false Derek Brunelle - Synthase Capital Partners Derek Brunelle - Synthase Capital Partners On Episode 9 of the podcast we discuss some common issues and pitfalls that Life Science founders struggle with then it comes to fundraising, and Derek Brunelle arms us with some tips to make your pitch deck more impactful.

]]> On Episode 9 of the podcast we discuss some common issues and pitfalls that Life Science founders struggle with then it comes to fundraising, and Derek Brunelle arms us with some tips to make your pitch deck more impactful.

]]> Bob McGriff and David Crean 7661e549-16a9-4850-bd30-8448f7013366 Mon, 11 Dec 2023 15:01:44 -0500 1311 false Emilie Gross PhD, MBA - Artificial Intelligence and Drug Discovery Emilie Gross PhD, MBA - Artificial Intelligence and Drug Discovery On this weeks podcast we catch up with Emilie Gross at BioSymetrics who is on the leading edge of Artificial Intelligence and Drug Discovery.

]]> On this weeks podcast we catch up with Emilie Gross at BioSymetrics who is on the leading edge of Artificial Intelligence and Drug Discovery.

]]> Bob McGriff and David Crean c613e1be-52a2-4572-97d6-94818f14855a Sun, 26 Nov 2023 22:53:17 -0500 998 false The Intersection of tech and Biotech with Nick Edwards The Intersection of tech and Biotech with Nick Edwards Nick Edwards is a serial entrepreneur working at the intersection of tech and biotech. He's currently building a company focused on AI tools for life sciences and is an Entrepreneur-in-Residence at the Allen Institute for AI. Nick's a neuroscientist by training. He did his PhD at Brown University and after a postdoc at UC San Diego, he spent time in consulting at BCG. In his free time, Nick is passionate about building the scientific ecosystem. He runs a podcast called Once a Scientist to help researchers learn about career options.

 

]]> Nick Edwards is a serial entrepreneur working at the intersection of tech and biotech. He's currently building a company focused on AI tools for life sciences and is an Entrepreneur-in-Residence at the Allen Institute for AI. Nick's a neuroscientist by training. He did his PhD at Brown University and after a postdoc at UC San Diego, he spent time in consulting at BCG. In his free time, Nick is passionate about building the scientific ecosystem. He runs a podcast called Once a Scientist to help researchers learn about career options.

 

]]> Bob McGriff and David Crean b43f4137-5b81-452f-9db6-d46336cbf7ba Tue, 14 Nov 2023 13:54:38 -0500 1242 false Episode 6 The Intersection of AI with Life Sciences Episode 6 The Intersection of AI with Life Sciences On episode 6 of the podcast, Bob and David reviewed the current state of the capital markets and deal flow for life sciences in 3Q 2023, as well as discussed the convergence of artificial intelligence (AI) with life sciences.

]]> On episode 6 of the podcast, Bob and David reviewed the current state of the capital markets and deal flow for life sciences in 3Q 2023, as well as discussed the convergence of artificial intelligence (AI) with life sciences.

]]> Bob McGriff and David Crean 53c78f22-5a5f-4420-b0b0-f2788fe83e44 Mon, 06 Nov 2023 19:21:38 -0500 1169 false Episode 5 - The Current State Of The Life Science Real Estate Market Episode 5 - The Current State Of The Life Science Real Estate Market This week on the podcast we turn the tables on Bob McGriff and we discuss the current state of the Life Science real estate market.

 

The Life Science real estate market has changed dramatically over the past 2 years.  If you were looking for a lab / life science space 16 to 24 months ago, then you were in a very competitive situation, and it was common to see Life science companies battling for lab space. Currently the life science lab space vacancies have spiked, and subleases are now at record numbers resulting in a much friendlier environment for Life Science Tenants.  Lab Space developers looking to take advantage of the hot life science market a couple years ago started building on new sites,  and now they have over 5 million square feet of new construction that will be adding to the inventory of vacant space over the next 12 months.   This will add more lab space to an already saturated market.

 

Life Science Landlords are scrambling to stop the bleeding and will typically add concessions and other incentive packages to entice lab occupiers to lease new space. Lab space rents are staying steady for now, but there is downward pressure on lease rates and it’s a good time to be a life science tenant looking for new real estate.   

 


]]> This week on the podcast we turn the tables on Bob McGriff and we discuss the current state of the Life Science real estate market.

 

The Life Science real estate market has changed dramatically over the past 2 years.  If you were looking for a lab / life science space 16 to 24 months ago, then you were in a very competitive situation, and it was common to see Life science companies battling for lab space. Currently the life science lab space vacancies have spiked, and subleases are now at record numbers resulting in a much friendlier environment for Life Science Tenants.  Lab Space developers looking to take advantage of the hot life science market a couple years ago started building on new sites,  and now they have over 5 million square feet of new construction that will be adding to the inventory of vacant space over the next 12 months.   This will add more lab space to an already saturated market.

 

Life Science Landlords are scrambling to stop the bleeding and will typically add concessions and other incentive packages to entice lab occupiers to lease new space. Lab space rents are staying steady for now, but there is downward pressure on lease rates and it’s a good time to be a life science tenant looking for new real estate.   

 


]]> Bob McGriff and David Crean 4dd02591-ee81-46a2-b324-fd65d2ccc154 Mon, 16 Oct 2023 16:36:36 -0400 1134 false CytoHub Founder and CEO - Rajib Biswas, PhD CytoHub Founder and CEO - Rajib Biswas, PhD On the podcast today, we have the dynamic founder andCEO of CytoHub, Rajib Biswas.

With a rich background in Cell and Gene Therapy, he's been at the helm of groundbreaking projects, bringing innovative cell-based therapies from the lab to the market. Equipped with a Ph.D. in Bioproducts and Sciences, he's not just about the tech but is deeply passionate about creating a brighter future for healthcare. A leader, a visionary, and above all, a young entrepreneur driven to make a difference

]]> On the podcast today, we have the dynamic founder andCEO of CytoHub, Rajib Biswas.

With a rich background in Cell and Gene Therapy, he's been at the helm of groundbreaking projects, bringing innovative cell-based therapies from the lab to the market. Equipped with a Ph.D. in Bioproducts and Sciences, he's not just about the tech but is deeply passionate about creating a brighter future for healthcare. A leader, a visionary, and above all, a young entrepreneur driven to make a difference

]]> Bob McGriff and David Crean e8ec197a-f6d0-49e3-bb08-815b26cd5d6f Thu, 05 Oct 2023 15:39:40 -0400 1065 false Westbrook Weaver - CEO of Tempo Therapeutics Westbrook Weaver - CEO of Tempo Therapeutics Westbrook Weaver, CEO of Tempo Therapeutics, provides insight and his perspective on successful capital financing of his life sciences company.

]]> Westbrook Weaver, CEO of Tempo Therapeutics, provides insight and his perspective on successful capital financing of his life sciences company.

]]> Bob McGriff and David Crean 0ace6aa8-eb6e-4f2e-a023-d4ec48441a7d Wed, 06 Sep 2023 19:03:23 -0400 1217 false Episode #2 Current State of Biopharma Episode #2 Current State of Biopharma The last year and a half has been exceptionally challenging for life sciences companies. We have seen many companies struggle to raise money while simultaneously tighten budgets, lay off their employee base, explore  multiple alternative avenues for financing,  and become more focused on priority programs to extend their runways.

With sentiment in the biopharma market improving during the second quarter of 2023, Co-hosts Bob and David Crean of Innovation Wave, explore what they are seeing in the market regarding supply and demand, private capital Venture financing, public market IPO’s and follow financings, and mergers and acquisitions (M&A).

Bob and David remain optimistic about the environment going forward.  The fundamentals of the ecosystem are strong with robust recovery anticipated in H2 2023 and early 2024.

]]> The last year and a half has been exceptionally challenging for life sciences companies. We have seen many companies struggle to raise money while simultaneously tighten budgets, lay off their employee base, explore  multiple alternative avenues for financing,  and become more focused on priority programs to extend their runways.

With sentiment in the biopharma market improving during the second quarter of 2023, Co-hosts Bob and David Crean of Innovation Wave, explore what they are seeing in the market regarding supply and demand, private capital Venture financing, public market IPO’s and follow financings, and mergers and acquisitions (M&A).

Bob and David remain optimistic about the environment going forward.  The fundamentals of the ecosystem are strong with robust recovery anticipated in H2 2023 and early 2024.

]]> Bob McGriff and David Crean fd469f8d-1846-4eee-9191-d28e6d99e716 Wed, 23 Aug 2023 13:02:19 -0400 1072 false Episode 1. A Life Science Ecosystem Podcast Episode 1. A Life Science Ecosystem Podcast Innovation Wave. What to expect in this podcast. Episode 1


Hosts Bob McGriff and David Crean discuss the theme and purpose behind creating this podcast. They also talk about the current state of Life Science funding and what to expect in the industry over the next several months.

The podcast will feature Life Science CEO's, Founders, and Influencers and serve the life science community and ecosystem.


]]> Innovation Wave. What to expect in this podcast. Episode 1


Hosts Bob McGriff and David Crean discuss the theme and purpose behind creating this podcast. They also talk about the current state of Life Science funding and what to expect in the industry over the next several months.

The podcast will feature Life Science CEO's, Founders, and Influencers and serve the life science community and ecosystem.


]]> Bob McGriff and David Crean 929033ea-5db3-4b66-8066-8289c52516be Mon, 07 Aug 2023 19:39:42 -0400 1071 1 1 false